Nebivolol
NDC Package 27241-182-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nebivolol is  tablets are contraindicated in the following conditions:Severe bradycardia Heart block greater than first degree Patients with cardiogenic shock Decompensated cardiac failure Sick sinus syndrome (unless a permanent pacemaker is in place) Patients with severe hepatic impairment (Child-Pugh >B) Patients who are hypersensitive to any component of this product. Marketed by Ajanta Pharma Usa Inc., this product is identified by NDC 27241-182 and is authorized under FDA application ANDA213349.

Identification & Billing

NDC Package Code
27241-182-90
Package Description
90 TABLET in 1 BOTTLE
Product Code
27241-182
11-Digit Billing Format
27241018290
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nebivolol
Dosage Form
-
Usage Information
Nebivolol tablets are contraindicated in the following conditions:Severe bradycardia Heart block greater than first degree Patients with cardiogenic shock Decompensated cardiac failure Sick sinus syndrome (unless a permanent pacemaker is in place) Patients with severe hepatic impairment (Child-Pugh >B) Patients who are hypersensitive to any component of this product.

Regulatory & Marketing

Labeler Name
Ajanta Pharma Usa Inc.
FDA Application #
ANDA213349
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-31-2022
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (27241-182). Click a package code to view its specific billing and regulatory data.

27241-182-30
30 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 27241-182-90 identifies a specific commercial package of 90 tablet in 1 bottle of Nebivolol, labeled by Ajanta Pharma Usa Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ajanta Pharma Usa Inc. on March 31, 2022. The current certification is valid through December 31, 2025.

How is this Ajanta Pharma Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 27241018290. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
27241-182-90
11-Digit CMS (5-4-2)
27241-0182-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.